Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer.
Journal Information
Full Title: CPT Pharmacometrics Syst Pharmacol
Abbreviation: CPT Pharmacometrics Syst Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"data s1 click here for additional data file."
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST STATEMENT A.G. and M.M. are Certara employees and were under contract with Genentech/Roche for this project. P.C., J.Y.J., and R.B., are Genentech/Roche employees and hold Roche stock or stock options. J.G. was a consultant for Genentech‐Roche for this work."
Funding Disclosure
Evidence found in paper:
"FUNDING INFORMATION This project was funded by Roche and Genentech."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025